Figure 7.
Figure 7. FACS analysis of BCR/ABL-expressing leukemic cells from bone marrow, peripheral blood, spleen, and pleural effusion of mice with B-ALL. Mice in both WT to WT and P-selectin-/-/ICAM1-/- to P-selectin-/-/ICAM1-/- groups showed similar percentages of GFP+/B220+ and GFP+/CD19+ myeloid cells in the spleen (Spl; P = .757 and .752), bone marrow (BM; P = .407 and .412), and pleural effusion (CE; P = .260 and .530), but significantly different percentages of GFP+/B220+ and GFP+/CD19+ myeloid cells in peripheral blood (PB; P = .002 and .006).

FACS analysis of BCR/ABL-expressing leukemic cells from bone marrow, peripheral blood, spleen, and pleural effusion of mice with B-ALL. Mice in both WT to WT and P-selectin-/-/ICAM1-/- to P-selectin-/-/ICAM1-/- groups showed similar percentages of GFP+/B220+ and GFP+/CD19+ myeloid cells in the spleen (Spl; P = .757 and .752), bone marrow (BM; P = .407 and .412), and pleural effusion (CE; P = .260 and .530), but significantly different percentages of GFP+/B220+ and GFP+/CD19+ myeloid cells in peripheral blood (PB; P = .002 and .006).

Close Modal

or Create an Account

Close Modal
Close Modal